Human Rise Pharma Private Limited
About Human Rise Pharma Private Limited
Data last updated:
Human Rise Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2014PTC270268. Its GSTIN is 07AADCH4545H1ZM (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sushil Kumar and Sachin Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 7 Main Road Pandav Nagar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.92 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹63,014 (net margin 4.5%) and EBITDA of ₹1.03 Lakh (EBITDA margin 7.4%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Human Rise Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 7 Main Road Pandav Nagar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Human Rise Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Human Rise Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Human Rise Pharma Private Limited, buy the company report.
Financials of Human Rise Pharma Private Limited
FY 2025 filings availableHuman Rise Pharma Private Limited reported revenue of ₹13.92 Lakh (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 15% fall in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63,014 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Human Rise Pharma Private Limited, buy the company report.
Board of directors of Human Rise Pharma Private Limited
Human Rise Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushil Kumar | Director | 12 Aug 2014 | 12 Years 2 Months | Current |
| Sachin Arora Also directs: R.S.B. Pharma Private Limited | Director | 12 Aug 2014 | 12 Years 2 Months | Current |
| Rakesh Kumar Tuteja Also directs: R.S.B. Pharma Private Limited | Director | 12 Aug 2014 | 12 Years 2 Months | Current |
| Baldev Raj Tuteja Also directs: R.S.B. Pharma Private Limited | Director | 12 Aug 2014 | 12 Years 2 Months | Current |
Peer comparison
Human Rise Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Konkan Combines Health Care Private Limited | ₹14 Lakh (FY 2017) | -29.0% | Mangalore, Karnataka, India | |||
| Human Rise Pharma Private Limitedthis company | ₹13.92 Lakh (FY 2025) | ₹63,014 | 4.5% | -15.0% | Delhi, India | |
| Crinat Pharmaceuticals Private Limited | ₹13.89 Lakh (FY 2025) | -3.0% | Namakkal, Tamil Nadu, India | |||
| Decorum Pharmaceuticals Private Limited | ₹13.87 Lakh (FY 2024) | -5.0% | Patna, Bihar, India |
To see the full peer comparison of Human Rise Pharma Private Limited, buy the company report.
Auditor
Human Rise Pharma Private Limited is audited by SHRUTI GOGIA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHRUTI GOGIA & ASSOCIATES | FY 2021 | 029252N |
Shareholding
The shareholding of Human Rise Pharma Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Human Rise Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Human Rise Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Human Rise Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Human Rise Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCH4545H1ZM | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Human Rise Pharma Private Limited, buy the company report.
Recent activity
Human Rise Pharma Private Limited has 4 board changes on record since 2014: 4 appointments. The latest: Baldev Raj Tuteja was appointed as Director on 12 Aug 2014.
Frequently asked questions
Human Rise Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 August 2014 (12+ years old) and is registered under CIN U74140DL2014PTC270268.
Human Rise Pharma has 4 current directors:
- Sushil Kumar - Director
- Sachin Arora - Director
- Rakesh Kumar Tuteja - Director
- Baldev Raj Tuteja - Director
The latest financial statements of Human Rise Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Human Rise Pharma is 07AADCH4545H1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Human Rise Pharma is U74140DL2014PTC270268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Human Rise Pharma was incorporated on 12 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Human Rise Pharma by revenue are Konkan Combines Health Care Private Limited, Crinat Pharmaceuticals Private Limited, Decorum Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Baldev Raj Tuteja was appointed as Director on 12 Aug 2014. Rakesh Kumar Tuteja was appointed as Director on 12 Aug 2014. Sachin Arora was appointed as Director on 12 Aug 2014. Human Rise Pharma has 4 board changes on record in total.
The registered office of Human Rise Pharma is at Plot No. 7 Main Road Pandav Nagar, Delhi, India – 110092.
Human Rise Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Human Rise Pharma is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.